Literature DB >> 21251130

Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.

Zhongwei Cheng1, Lin Kang, Zhuang Tian, Weiyun Chen, Wenjuan Guo, Jia Xu, Taibo Chen, Ligang Fang, Yong Zeng, Kang'an Cheng, Quan Fang.   

Abstract

OBJECTIVE: Primary cardiac amyloidosis (CA) is associated with poor prognosis. However, the noninvasive diagnostic tools are limited. The aim of the study is to assess the utility of combined indexes of electrocardiography (ECG) and echocardiography (ECHO) in the diagnosis of primary CA.
METHODS: A total of 20 consecutive patients (7 men, mean age 50 ± 12 years) referred for endomyocardial biopsy (EMB) were included. Eleven of these patients (55%) confirmed primary CA, the rest of 9 patients were EMB negative and used for the control.
RESULTS: The voltage of S(V1) + R(V6) < 1.2 mV has a sensitivity of 91% and specificity of 89% for the identification of primary CA, yields the positive and negative predictive values of 91% and 89%, respectively. Among ECHO parameters, there were no significant differences between the 2 groups, except for left ventricular ejection fraction (47 ± 12% in primary CA vs 67 ± 11% in the control, P < 0.001). However, the combined indexes of ECG and ECHO parameters, including the ratio of R(I) /LVPW as well as R(V5) /LVPW and R(V6) /LVPW, were significantly lower in the patients with primary CA than the control. The ratio of R(I) /LVPW < 0.4 has the sensitivity of 91% and specificity of 100%, yields the positive and negative predictive values of 100% and 91%, respectively. The ratios of R(V5(6)) /LVPW < 0.7 have the sensitivity of 91% and specificity of 89%, yield the positive and negative predictive values of 91% and 89%, respectively.
CONCLUSION: Patients with clinically suspected primary CA, combined indexes of ECGs and ECHOs could be used as the noninvasive diagnostic tools. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21251130      PMCID: PMC6932607          DOI: 10.1111/j.1542-474X.2010.00403.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  14 in total

1.  Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report.

Authors:  Julius M Gardin; David B Adams; Pamela S Douglas; Harvey Feigenbaum; David H Forst; Alan G Fraser; Paul A Grayburn; Alan S Katz; Andrew M Keller; Richard E Kerber; Bijoy K Khandheria; Allan L Klein; Roberto M Lang; Luc A Pierard; Miguel A Quinones; Ingela Schnittger
Journal:  J Am Soc Echocardiogr       Date:  2002-03       Impact factor: 5.251

2.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Authors:  Blaithnead Murtagh; Stephen C Hammill; Morie A Gertz; Robert A Kyle; A Jamil Tajik; Martha Grogan
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

Review 3.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

Review 4.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

5.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

Review 6.  Evaluation and management of the cardiac amyloidosis.

Authors:  Joseph B Selvanayagam; Philip N Hawkins; Biju Paul; Saul G Myerson; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

7.  Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.

Authors:  Bethany A Austin; Brendan Duffy; Carmela Tan; E Rene Rodriguez; Randall C Starling; Milind Y Desai
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

8.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

9.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

Authors:  Joseph E Rahman; Emelie F Helou; Ramona Gelzer-Bell; Richard E Thompson; Chih Kuo; E Rene Rodriguez; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

10.  Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.

Authors:  J D Carroll; W H Gaasch; K P McAdam
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

View more
  7 in total

1.  Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Authors:  Roberta Mussinelli; Francesco Salinaro; Alessio Alogna; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

Review 2.  Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis.

Authors:  Perryn Lin Fei Ng; Yoke Ching Lim; Lauren Kay Mance Evangelista; Raymond Ching Chiew Wong; Ping Chai; Ching Hui Sia; Hoi Yin Loi; Tiong Cheng Yeo; Weiqin Lin
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-05-14       Impact factor: 1.485

3.  The findings of electrocardiography in patients with cardiac amyloidosis.

Authors:  Zhongwei Cheng; Kongbo Zhu; Zhuang Tian; Dachun Zhao; Quancai Cui; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

Review 4.  Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors:  Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

5.  Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.

Authors:  Darae Kim; Ga Yeon Lee; Jin-Oh Choi; Kihyun Kim; Seok Jin Kim; Eun-Seok Jeon
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

6.  Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.

Authors:  Jeremy A Slivnick; Alexander L Wallner; Ajay Vallakati; Vien T Truong; Wojciech Mazur; Mohamed B Elamin; Matthew S Tong; Subha V Raman; Karolina M Zareba
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-17       Impact factor: 2.357

7.  Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis.

Authors:  Angela Pucci; Alberto Aimo; Veronica Musetti; Andrea Barison; Giuseppe Vergaro; Dario Genovesi; Assuero Giorgetti; Silvia Masotti; Chiara Arzilli; Concetta Prontera; Luigi Emilio Pastormerlo; Michele Alessandro Coceani; Marco Ciardetti; Nicola Martini; Cataldo Palmieri; Claudio Passino; Claudio Rapezzi; Michele Emdin
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.